CSP exam test specialty pharmacy 2025

CSP exam test specialty pharmacy 2025
PDC calculation - Correct Answers PDC = (# of unique days with supply / number of days in a period) x 100
IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi




IIi Which medication is a Jak inhibitor?
IIi IIi IIi IIi IIi




a. Humira (adalimumab)
IIi IIi




b. Orencia (abatacept)
IIi IIi




c. Actemra (toclizumab)
IIi IIi




d. Xeljanz (tofacitinib) - Correct Answers d. Xeljanz (tofacitinib)
IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi




IIi Which medication can elevate cholesterol?
IIi IIi IIi IIi




a. Actemra (toclizumab)
IIi IIi




b. Enbrel (etanercept)
IIi IIi




c. Simponi (golimumab)
IIi IIi




d. Kineret (anakinra) - Correct Answers a. Actemra (toclizumab)
IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi




IIi Which shingles vaccine is safe to administer with TNF inhibitors?
IIi IIi IIi IIi IIi IIi IIi IIi IIi




a. Adacel
IIi




b. Zostavax
IIi




c. Shingrix
IIi




d. Varivax - Correct Answers c. Shingrix
IIi IIi IIi IIi IIi IIi IIi IIi




IIi Most biologics increase the risk of infections, which of the following also increases the risk of
IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi




neutropenia?

a. Rituxin (rituximab)
IIi IIi




b. Taltz (ixekizumab)
IIi IIi




c. Remicade (infliximab)
IIi IIi




d. Cimzia (certolizumab pegol) - Correct Answers b. Taltz (ixekizumab)
IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi

, IIi Which psoriasis medication does not require screening for tuberculosis?
IIi IIi IIi IIi IIi IIi IIi IIi




a. Stelara (ustekinumab)
IIi IIi




b. Otezla (apremilast)
IIi IIi




c. Cocentyx (seculinumab)
IIi IIi




d. Humira (adalimumab) - Correct Answers b. Otezla (apremilast)
IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi




IIi What is the standard starting dose for Taltz (ixekizumab) when used to treat psoriatic arthritis?
IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi




a. 160mg subcutaneously once, followed by 80mg subcutaneously at weeks 2, 4, 6, 8, 10
IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi




and 12; then 80mg subcutaneously every 4 weeks
IIi IIi IIi IIi IIi IIi IIi




b. 160mg subcutaneously once, followed by 80mg subcutaneously every 4 weeks
IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi




c. 160mg subcutaneously once, followed by 80mg subcutaneously every week for 4 weeks,
IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi




then 80mg every 4 weeks
IIi IIi IIi IIi




d. 160mg subcutaneously once, followed by 80mg subcutaneously every other week - Correct Answers b.
IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi




160mg subcutaneously once, followed by 80mg subcutaneously every 4 weeks
IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi




IIi A 45 y/o, 200lb patient is struggling with severe dermatitis and the provider wants to potentially
IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi




start a biologic. Which medication would you recommend?
IIi IIi IIi IIi IIi IIi IIi




a. Protopic (tacrolimus)
IIi IIi




b. Humira (adalimumab)
IIi IIi




c. Stelara (ustekinumab)
IIi IIi




d. Dupixent (dupilumab) - Correct Answers d. Dupixent (dupilumab)
IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi




IIi A 56 y/o, 140lb patient with psoriasis will be starting Stelara (ustekinumab), but the provider
IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi




wants to verify the dosing of the medication. What starting dose would you recommend?
IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi




a. Inject 45 mg subcutaneously at weeks 0 and 4, followed by 45 mg every 12 weeks
IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi




b. Inject 90 mg subcutaneously at weeks 0 and 4, followed by 90 mg every 12 weeks
IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi




c. Infuse 260 mg IV over at least 1 hour as a single dose, followed 8 weeks later with 90 mg
IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi




subcutaneously every 8 weeks IIi IIi IIi




d. Infuse 520 mg IV over at least 1 hour as a single dose, followed 8 weeks later with 90 mg
IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi IIi